Detalhe da pesquisa
1.
Phenotypic changes in low-density lipoprotein particles as markers of adverse clinical outcomes in COVID-19.
Mol Genet Metab
; 138(4): 107552, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36889041
2.
Role of LOX-1 (Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1) as a Cardiovascular Risk Predictor: Mechanistic Insight and Potential Clinical Use.
Arterioscler Thromb Vasc Biol
; 41(1): 153-166, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33176449
3.
LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody MEDI5884 in Patients With Stable Coronary Artery Disease.
Arterioscler Thromb Vasc Biol
; 41(12): 3005-3014, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34706556
4.
COVID-19-Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches.
FASEB J
; 34(8): 9843-9853, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32588493
5.
A new phenotypic classification system for dyslipidemias based on the standard lipid panel.
Lipids Health Dis
; 20(1): 170, 2021 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34838008
6.
Novel lecithin: cholesterol acyltransferase-based therapeutic approaches.
Curr Opin Lipidol
; 31(2): 71-79, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32073411
7.
Lecithin:cholesterol acyltransferase: symposium on 50 years of biomedical research from its discovery to latest findings.
J Lipid Res
; 61(8): 1142-1149, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32482717
8.
Recombinant LCAT (Lecithin:Cholesterol Acyltransferase) Rescues Defective HDL (High-Density Lipoprotein)-Mediated Endothelial Protection in Acute Coronary Syndrome.
Arterioscler Thromb Vasc Biol
; 39(5): 915-924, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30894011
9.
Plasma lipoprotein-X quantification on filipin-stained gels: monitoring recombinant LCAT treatment ex vivo.
J Lipid Res
; 60(5): 1050-1057, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30808683
10.
LCAT Enzyme Replacement Therapy Reduces LpX and Improves Kidney Function in a Mouse Model of Familial LCAT Deficiency.
J Pharmacol Exp Ther
; 368(3): 423-434, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30563940
11.
Genetic and secondary causes of severe HDL deficiency and cardiovascular disease.
J Lipid Res
; 59(12): 2421-2435, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30333156
12.
The Changing Face of HDL and the Best Way to Measure It.
Clin Chem
; 63(1): 196-210, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27879324
13.
Clinical Progress in Cell Therapy for Single Ventricle Congenital Heart Disease.
Circ Res
; 120(7): 1060-1062, 2017 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-28360342
14.
Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Inhibition in Type 2 Diabetes: Phase 1 Results.
J Am Heart Assoc
; 12(3): e027540, 2023 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36688371
15.
Relationship of Soluble Lectin-Like Low-Density Lipoprotein Receptor-1 (sLOX-1) With Inflammation and Coronary Plaque Progression in Psoriasis.
J Am Heart Assoc
; : e031227, 2023 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37982276
16.
Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance.
Cell Metab
; 5(3): 167-79, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17339025
17.
A Simple Fluorescent Cholesterol Labeling Method to Cryoprotect and Detect Plasma Lipoprotein-X.
Biology (Basel)
; 11(8)2022 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36009874
18.
Recombinant human lecithin-cholesterol acyltransferase in patients with atherosclerosis: phase 2a primary results and phase 2b design.
Eur Heart J Cardiovasc Pharmacother
; 8(3): 243-252, 2022 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33493256
19.
Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure.
J Lipid Res
; 52(12): 2169-2176, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21957197
20.
MEDI6012: Recombinant Human Lecithin Cholesterol Acyltransferase, High-Density Lipoprotein, and Low-Density Lipoprotein Receptor-Mediated Reverse Cholesterol Transport.
J Am Heart Assoc
; 10(13): e014572, 2021 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34121413